Pzena Investment Management LLC Boosts Holdings in Amdocs Limited $DOX

Pzena Investment Management LLC grew its stake in Amdocs Limited (NASDAQ:DOX) by 5.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,681,089 shares of the technology company’s stock after purchasing an additional 644,074 shares during the quarter. Amdocs makes up 2.7% of Pzena Investment Management LLC’s holdings, making the stock its 12th biggest position. Pzena Investment Management LLC owned about 11.75% of Amdocs worth $827,568,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Alyeska Investment Group L.P. lifted its stake in Amdocs by 155.1% in the 4th quarter. Alyeska Investment Group L.P. now owns 2,110,393 shares of the technology company’s stock valued at $169,908,000 after buying an additional 1,283,231 shares in the last quarter. Alliancebernstein L.P. increased its stake in Amdocs by 32.1% during the 3rd quarter. Alliancebernstein L.P. now owns 2,359,779 shares of the technology company’s stock worth $193,620,000 after buying an additional 573,349 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Amdocs by 24.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,892,761 shares of the technology company’s stock worth $232,903,000 after buying an additional 560,380 shares in the last quarter. Squarepoint Ops LLC raised its holdings in shares of Amdocs by 469.4% during the fourth quarter. Squarepoint Ops LLC now owns 543,875 shares of the technology company’s stock valued at $43,787,000 after acquiring an additional 448,358 shares during the last quarter. Finally, Voloridge Investment Management LLC lifted its position in shares of Amdocs by 501.1% in the fourth quarter. Voloridge Investment Management LLC now owns 520,494 shares of the technology company’s stock valued at $41,905,000 after acquiring an additional 433,907 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

Amdocs stock opened at $51.18 on Thursday. The firm has a 50 day simple moving average of $59.69 and a 200-day simple moving average of $68.49. Amdocs Limited has a 1-year low of $49.79 and a 1-year high of $93.44. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.98 and a quick ratio of 0.98. The stock has a market cap of $5.52 billion, a price-to-earnings ratio of 10.24, a price-to-earnings-growth ratio of 0.88 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 EPS for the quarter, beating the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.78 EPS. On average, analysts expect that Amdocs Limited will post 6.56 EPS for the current year.

Amdocs Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.569 dividend. This represents a $2.28 annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Tuesday, June 30th. Amdocs’s dividend payout ratio is 45.60%.

Wall Street Analyst Weigh In

DOX has been the topic of a number of research analyst reports. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. KeyCorp started coverage on shares of Amdocs in a research note on Monday. They set a “sector weight” rating on the stock. Cfra lowered shares of Amdocs to a “sell” rating in a report on Thursday, May 14th. Finally, Stifel Nicolaus reduced their target price on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Amdocs presently has a consensus rating of “Hold” and a consensus price target of $86.67.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.